UCHL1 demonstrated dual roles in different tumors: as an oncogene in lymphoma [40], colorectal cancer [41] and B-cell [42], as a tumor suppressor in nasopharyngeal carcinoma [43], PCa [44], and ovarian cancer [45]. Here, UCHL1 is linked to nasopharyngeal carcinoma.